Evidence map›Paper›PMID 29318559›Full record

ArticleMethods in molecular biology (Clifton, N.J.)2018

Imaging Proteolytic Activities in Mouse Models of Cancer.

Anupama Pal, Alnawaz Rehemtulla

Open access · greenAbstract readValidation Study
In one paragraph

Article in Methods in molecular biology (Clifton, N.J.), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 99% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Anupama PalDepartment of Radiation Oncology, University of Michigan, Ann Arbor, MI, USA.
Alnawaz RehemtullaDepartment of Radiation Oncology, University of Michigan, Ann Arbor, MI, USA. Alnawaz@umich.edu.
University of Michigan–Ann Arbor · US

Funding

QUANTITATION OF HUMAN BRAIN TUMOR THERAPY RESPONSE BY MRP01CA085878 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI CHENEVERT, THOMAS L · 2001 to 2017
$31.9M
Sensitization to Chemoradiation by Therapeutic Targeting of the DNA Damage ResponseU01CA216449 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI LAWRENCE, THEODORE S · 2017 to 2021
$3.0M
Efficacy of PDI inhibitors in glioblastomaR01CA193690 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI NEAMATI, NOURI, REHEMTULLA, ALNAWAZ · 2015 to 2019
$2.4M
NCI NIH HHS P01 CA085878NCI NIH HHS R01 CA193690NCI NIH HHS U01 CA216449
6 · The paper itself

Abstract

Proteases are "protein-cleaving" enzymes, which, in addition to their non-specific degrading function, also catalyze the highly specific and regulated process of proteolytic processing, thus regulating multiple biological functions. Alterations in proteolytic activity occur during pathological conditions such as cancer. One of the major deregulated classes of proteases in cancer is caspases, the proteolytic initiators and mediators of the apoptotic machinery. The ability to image apoptosis noninvasively in living cells and animal models of cancer can not only provide new insight into the biological basis of the disease but can also be used as a quantitative tool to screen and evaluate novel therapeutic strategies. Optical molecular imaging such as bioluminescence-based genetically engineered biosensors has been developed in our laboratory and exploited to study protease activity in animal models with a high signal to noise. Using the circularly permuted form of firefly luciferase, we have developed a reporter for Caspase 3/7, referred to as Caspase 3/7 GloSensor. Here, we discuss the use of the Caspase 3/7 GloSensor for imaging apoptotic activity in mouse xenografts and genetically engineered mouse models of cancer and present the potential of this powerful platform technology to image the proteolytic activity of numerous other proteases.

Indexed as

ProteolysisAnimalsApoptosisBiosensing TechniquesCaspase 3Caspase 7Cell Line, TumorFemaleGenes, ReporterGenetic EngineeringHumansLuciferases, FireflyLuminescent AgentsLuminescent MeasurementsMiceMice, NudeCaspase 3Caspase 7Luciferases, FireflyLuminescent AgentsCancerCaspase 3/7Firefly luciferaseGloSensorMouse modelsProteases

Identifiers

PMID29318559
PMCPMC6435259
OpenAlexW2783520648

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.